A First-in-Human Escalation and Expansion Study of Patients With Advanced Solid Tumors

This is a first-in-human study testing a new experimental drug in people with advanced solid tumors that have progressed on or become resistant to all available standard treatments. The study aims to determine a safe dose and observe early signs of effectiveness. **You may be eligible if...** - You are 18 or older - You have a locally advanced or metastatic solid tumor with no remaining standard treatment options - You have measurable disease on imaging - Your life expectancy is at least 3 months - Your blood counts, liver, and kidney function are within acceptable limits **You may NOT be eligible if...** - Your organ function is inadequate - You are pregnant or breastfeeding - You have active serious infections or uncontrolled medical conditions - Your cancer has not progressed on all standard therapies Talk to your doctor to see if this trial is right for you.